These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26363679)

  • 1. A comparison of multiple patient reported outcome measures in identifying major depressive disorder in people with multiple sclerosis.
    Amtmann D; Bamer AM; Johnson KL; Ehde DM; Beier ML; Elzea JL; Bombardier CH
    J Psychosom Res; 2015 Dec; 79(6):550-7. PubMed ID: 26363679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the best screening test for depression in chronic spinal pain patients?
    Choi Y; Mayer TG; Williams MJ; Gatchel RJ
    Spine J; 2014 Jul; 14(7):1175-82. PubMed ID: 24225008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of four screening scales for major depression in MS.
    Patten SB; Burton JM; Fiest KM; Wiebe S; Bulloch AG; Koch M; Dobson KS; Metz LM; Maxwell CJ; Jetté N
    Mult Scler; 2015 Jul; 21(8):1064-71. PubMed ID: 25583846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis.
    Amtmann D; Kim J; Chung H; Bamer AM; Askew RL; Wu S; Cook KF; Johnson KL
    Rehabil Psychol; 2014 May; 59(2):220-229. PubMed ID: 24661030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating CESD-20 and PHQ-9 Scores to PROMIS Depression.
    Kim J; Chung H; Askew RL; Park R; Jones SM; Cook KF; Amtmann D
    Assessment; 2017 Apr; 24(3):300-307. PubMed ID: 26423348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis.
    Marrie RA; Zhang L; Lix LM; Graff LA; Walker JR; Fisk JD; Patten SB; Hitchon CA; Bolton JM; Sareen J; El-Gabalawy R; Marriott JJ; Bernstein CN
    Mult Scler Relat Disord; 2018 Feb; 20():9-15. PubMed ID: 29274564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires.
    Fischer A; Fischer M; Nicholls RA; Lau S; Poettgen J; Patas K; Heesen C; Gold SM
    Brain Behav; 2015 Sep; 5(9):e00365. PubMed ID: 26445703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression in multiple sclerosis: The utility of common self-report instruments and development of a disease-specific measure.
    Strober LB; Arnett PA
    J Clin Exp Neuropsychol; 2015; 37(7):722-32. PubMed ID: 26223270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing depression in a geriatric cancer population.
    Saracino RM; Weinberger MI; Roth AJ; Hurria A; Nelson CJ
    Psychooncology; 2017 Oct; 26(10):1484-1490. PubMed ID: 27195436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in multiple sclerosis.
    Avasarala JR; Cross AH; Trinkaus K
    Mult Scler; 2003 Jun; 9(3):307-10. PubMed ID: 12814181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the Beck Depression Inventory in measuring major depression among individuals seeking HIV testing in the Western Cape, South Africa.
    Saal W; Kagee A; Bantjes J
    AIDS Care; 2018; 30(sup1):29-36. PubMed ID: 30021462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the telephone-administered PHQ-9 against the in-person administered SCID-I major depression module.
    Fine TH; Contractor AA; Tamburrino M; Elhai JD; Prescott MR; Cohen GH; Shirley E; Chan PK; Goto T; Slembarski R; Liberzon I; Galea S; Calabrese JR
    J Affect Disord; 2013 Sep; 150(3):1001-7. PubMed ID: 23747208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and validity of the Beck Depression Inventory-Fast Screen for medical patients in the general German population.
    Kliem S; Mößle T; Zenger M; Brähler E
    J Affect Disord; 2014 Mar; 156():236-9. PubMed ID: 24480380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review.
    Patrick S; Connick P
    PLoS One; 2019; 14(2):e0197943. PubMed ID: 30779803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. People with multiple sclerosis report significantly worse symptoms and health related quality of life than the US general population as measured by PROMIS and NeuroQoL outcome measures.
    Amtmann D; Bamer AM; Kim J; Chung H; Salem R
    Disabil Health J; 2018 Jan; 11(1):99-107. PubMed ID: 28442320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the Patient Health Questionnaire-9 in assessing major depressive disorder during inpatient spinal cord injury rehabilitation.
    Bombardier CH; Kalpakjian CZ; Graves DE; Dyer JR; Tate DG; Fann JR
    Arch Phys Med Rehabil; 2012 Oct; 93(10):1838-45. PubMed ID: 22555007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms of major depression in people with spinal cord injury: implications for screening.
    Bombardier CH; Richards JS; Krause JS; Tulsky D; Tate DG
    Arch Phys Med Rehabil; 2004 Nov; 85(11):1749-56. PubMed ID: 15520969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telephone-based physical activity counseling for major depression in people with multiple sclerosis.
    Bombardier CH; Ehde DM; Gibbons LE; Wadhwani R; Sullivan MD; Rosenberg DE; Kraft GH
    J Consult Clin Psychol; 2013 Feb; 81(1):89-99. PubMed ID: 23379265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Psychometric Properties and Responsiveness to Change of 3 Depression Measures in a Sample of Persons With Traumatic Spinal Cord Injury and Major Depressive Disorder.
    Williams RT; Heinemann AW; Neumann HD; Fann JR; Forchheimer M; Richardson EJ; Bombardier CH;
    Arch Phys Med Rehabil; 2016 Jun; 97(6):929-37. PubMed ID: 26859610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation and validation of the multiple sclerosis depression rating scale: a test specifically devised to investigate affective disorders in multiple sclerosis patients.
    Quaranta D; Marra C; Zinno M; Patanella AK; Messina MJ; Piccininni C; Batocchi AP; Gainotti G
    Clin Neuropsychol; 2012; 26(4):571-87. PubMed ID: 22428778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.